TRVI vs. DXPE
TRVI (Trevi Therapeutics, Inc.) and DXPE (DXP Enterprises, Inc.) are both stocks. TRVI operates in Biotechnology (Healthcare), while DXPE operates in Industrial Distribution (Industrials). Over the past 5 years, TRVI returned 44.83%/yr vs 39.05%/yr for DXPE. At a 0.15 correlation, their price movements are largely independent.
Performance
TRVI vs. DXPE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TRVI achieves a 13.50% return, which is significantly lower than DXPE's 53.85% return.
TRVI
- 1D
- 5.57%
- 1M
- -6.94%
- YTD
- 13.50%
- 6M
- 11.28%
- 1Y
- 130.31%
- 3Y*
- 75.70%
- 5Y*
- 44.83%
- 10Y*
- —
DXPE
- 1D
- 0.88%
- 1M
- 15.49%
- YTD
- 53.85%
- 6M
- 54.45%
- 1Y
- 114.27%
- 3Y*
- 67.49%
- 5Y*
- 39.05%
- 10Y*
- 27.71%
TRVI vs. DXPE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
TRVI Trevi Therapeutics, Inc. | 13.50% | 203.88% | 207.46% | -30.57% | 146.74% | -67.68% | -35.47% | -60.53% |
DXPE DXP Enterprises, Inc. | 53.85% | 32.89% | 145.16% | 22.32% | 7.32% | 15.47% | -44.16% | -8.48% |
Correlation
The correlation between TRVI and DXPE is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since May 7, 2019 | 0.15 |
Fundamentals
TRVI:
-$0.43
DXPE:
$5.35
TRVI:
$0.00
DXPE:
$2.06B
TRVI:
-$31.00K
DXPE:
$654.27M
TRVI:
-$49.16M
DXPE:
$210.11M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TRVI vs. DXPE — Risk / Return Rank
TRVI
DXPE
TRVI vs. DXPE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Trevi Therapeutics, Inc. (TRVI) and DXP Enterprises, Inc. (DXPE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| TRVI | DXPE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.05 | ||
| Sortino ratioReturn per unit of downside risk | +0.33 | ||
| Omega ratioGain probability vs. loss probability | 1.35 | 1.35 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 4.44 | 3.48 | +0.96 |
| Martin ratioReturn relative to average drawdown | 10.40 | 9.64 | +0.76 |
Loading charts...
Drawdowns
TRVI vs. DXPE - Drawdown Comparison
The maximum TRVI drawdown since its inception was -95.45%, roughly equal to the maximum DXPE drawdown of -95.45%. Use the drawdown chart below to compare losses from any high point for TRVI and DXPE.
Loading charts...
Drawdown Indicators
| TRVI | DXPE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.45% | -95.45% | 0.00% |
Max Drawdown (1Y)Largest decline over 1 year | -29.50% | -32.99% | +3.49% |
Max Drawdown (3Y)Largest decline over 3 years | -61.96% | -32.99% | -28.97% |
Max Drawdown (5Y)Largest decline over 5 years | -80.26% | -37.98% | -42.28% |
Max Drawdown (10Y)Largest decline over 10 years | — | -77.28% | — |
Current DrawdownCurrent decline from peak | -7.73% | -6.94% | -0.79% |
Average DrawdownAverage peak-to-trough decline | -61.49% | -54.49% | -7.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.58% | 11.90% | +0.68% |
Volatility
TRVI vs. DXPE - Volatility Comparison
Trevi Therapeutics, Inc. (TRVI) has a higher volatility of 13.78% compared to DXP Enterprises, Inc. (DXPE) at 12.93%. This indicates that TRVI's price experiences larger fluctuations and is considered to be riskier than DXPE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TRVI | DXPE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.78% | 12.93% | +0.85% |
Volatility (6M)Calculated over the trailing 6-month period | 39.38% | 35.29% | +4.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 60.39% | 51.74% | +8.65% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 88.26% | 45.37% | +42.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 99.35% | 56.01% | +43.34% |
Dividends
TRVI vs. DXPE - Dividend Comparison
Neither TRVI nor DXPE has paid dividends to shareholders.
Financials
TRVI vs. DXPE - Financials Comparison
This section allows you to compare key financial metrics between Trevi Therapeutics, Inc. and DXP Enterprises, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TRVI and DXPE have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
TRVI has higher volatility (13.78%) compared to DXPE (12.93%). In terms of maximum drawdown, TRVI dropped -95.45% vs DXPE's -95.45%.
DXPE currently has the higher Sharpe Ratio (2.22 vs 2.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TRVI and DXPE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer